Ethanol interactions with other cytochrome P450 substrates including drugs, xenobiotics, and carcinogens

被引:0
|
作者
Djordjevic, D
Nikolic, J
Stefanovic, V
机构
[1] Univ Nish, Sch Med, Inst Nephrol & Hemodialysis, YU-18000 Nish, Yugoslavia
[2] Univ Nish, Sch Med, Dept Neonatol, YU-18000 Nish, Yugoslavia
[3] Univ Nish, Sch Med, Inst Biochem, YU-18000 Nish, Yugoslavia
来源
PATHOLOGIE BIOLOGIE | 1998年 / 46卷 / 10期
关键词
ethanol; enzyme induction; drug interactions; toxic agent interactions;
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Chronic ethanol abuse is associated with increased activity of the microsomal ethanol-oxidizing system. This effect is due primarily to induction by ethanol of a specific cytochrome P450 (CYP2E1) responsible for enhanced oxidation of ethanol and other P450 substrates and consequently, for metabolic tolerance to these substances. Furthermore, cytochrome 450 induction increases the activation of numerous xenobiotics to toxic metabolites and of chemical carcinogens to reactive metabolites, thereby accelerating their adverse effects. Microsomal enzyme induction has been associated with increased reactive oxygen species production and enhanced lipid peroxidation, as well as with decreased enzymatic and nonenzymatic scavenger activity, providing another possible explanation for ethanol-mediated toxicity. Yet another effect of chronic alcohol abuse is chronic immune system activation, which is the mechanism underlying alcohol-related liver disease. The metabolism of steroids and vitamins is catalyzed by P350 and is altered in chronic alcoholics. This article reviews recent advances in the understanding of ethanol interactions with drugs, toxic agents, and carcinogens, as well as with steroids and vitamins.
引用
收藏
页码:760 / 770
页数:11
相关论文
共 50 条
  • [21] Cytochrome P450 monooxygenases for fatty acids and xenobiotics in marine macroalgae
    Pflugmacher, S
    Sandermann, H
    PLANT PHYSIOLOGY, 1998, 117 (01) : 123 - 128
  • [22] Human cytochrome P450 enzymes bind drugs and other substrates mainly through conformational-selection modes
    Guengerich, F. Peter
    Wilkey, Clayton J.
    Phan, Thanh T. N.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (28) : 10928 - 10941
  • [23] Cytochrome P450: Structure and interactions - Foreword
    Hon, GHB
    BIOCHIMIE, 1996, 78 (8-9) : 683 - 684
  • [24] Studies on cytochrome P450 reductase interactions
    Korzekwa, KR
    Shou, M
    Grogan, J
    Parise, R
    FASEB JOURNAL, 1997, 11 (09): : A771 - A771
  • [25] Role of cytochrome P450 in drug interactions
    Zakia Bibi
    Nutrition & Metabolism, 5
  • [26] Opioid Therapies and Cytochrome P450 Interactions
    Gudin, Jeffrey
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2012, 44 (06) : S4 - S14
  • [27] Cytochrome P450 structures and their substrate interactions
    Lewis, DFV
    Ito, Y
    Goldfarb, PS
    DRUG DEVELOPMENT RESEARCH, 2005, 66 (01) : 19 - 24
  • [28] Alcohol-xenobiotics interactions. Role of cytochrome P450 2E1.
    Meskar, A
    Plee-Gautier, E
    Amet, Y
    Berthou, F
    Lucas, D
    PATHOLOGIE BIOLOGIE, 2001, 49 (09): : 696 - 702
  • [29] Effect of Sarizotan on a cocktail of cytochrome P450 substrates
    Krösser, S
    Neugebauer, R
    Dolgos, H
    Kovar, A
    JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (10): : 1196 - 1196
  • [30] Modified fatty acids as cytochrome P450 substrates
    De Voss, JJ
    Cryle, MJ
    Hayes, PY
    Proceedings of the 14th International Conference on Cytochromes P450: Biochemistry, Biophysics, and Bioinformatics, 2005, : 109 - 114